McKesson and CD&R take Option Care private for $5.8B
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care Health private in a $5.8 billion transaction.
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care Health private in a $5.8 billion transaction.
Britain's Informa will acquire B2B events firm Clarion for £2.24 billion ($2.96 billion) and separate its academic publishing arm, Taylor & Francis, into a standalone entity.
In 2025, global healthcare private equity reached a record $191 billion in deal value, exceeding the previous peak set in 2021, with firms targeting AI integration and physician practices.
GTCR bought PE-backed action camera company Tactacam in a secondary acquisition valued at over $1 billion, reflecting strong demand in the automotive and personal device markets.
Swiss private bank Julius Baer announced a share buyback program of up to 600 million Swiss francs ($723 million) following recent regulatory intervention.
Corporate share and bond issuance fell more than 10 trillion won in August, with direct financing plummeting approximately 38% in a single month as domestic firms pulled back from capital markets.
Tokyo-based Startale Japan issued the nation's first yen-denominated stablecoin-settled corporate bond, integrating digital currency payments into real-world debt instruments.